about
Impact of NGS in the medical sciences: Genetic syndromes with an increased risk of developing cancer as an example of the use of new technologiesEpigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.Angiomyolipomas, renal cell carcinomas and pulmonary lymphangioleiomyomatosis.Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysisThe mTOR signaling pathway as a treatment target for intracranial neoplasmsMonoallelic germline TSC1 mutations are permissive for T lymphocyte development and homeostasis in tuberous sclerosis complex individuals.Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patientsTuberous sclerosis associated with polycystic kidney disease: effects of rapamycin after renal transplantation.Deficiency in pulmonary surfactant proteins in mice with fatty acid binding protein 4-Cre-mediated knockout of the tuberous sclerosis complex 1 gene.The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.Bilateral renal cell carcinoma in a paediatric patient with tuberous sclerosis complex.Do you know this syndrome?Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiencyTMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.Tuberous sclerosis complex: Recent advances in manifestations and therapy.Tuberous sclerosis with head injuryA vascular model of Tsc1 deficiency accelerates renal tumor formation with accompanying hemangiosarcomas.Tuberous sclerosis complex-associated renal angiomyolipomas: A single center study of 17 consecutive casesEvidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells.Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome.Multifocal and microscopic chromophobe renal cell carcinomatous lesions associated with 'capsulomas' without FCLN gene abnormality.The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.
P2860
Q27694653-67B59491-F5F0-49D6-B19F-52AD6A27E463Q34532204-A16C9CC6-3B40-4313-BD1A-2FFD8D39DAADQ34589342-6529884C-A2D2-4346-9E1B-C93FE72600C8Q34618235-8AE7039B-9E51-4CC5-9886-7FBF295A7213Q34795499-9505AB1A-90F8-4F0E-91C0-C45C41ABC5F4Q34886859-24A3DA8E-DA8D-4A2B-AE63-9ECB68475354Q35122010-FE691687-C52D-42AD-B587-EF00C0BACCDDQ35847355-2D95CA5C-663C-4B31-AB82-30694FD76C1CQ36241426-C6A131AE-6510-47EA-8434-C1576E7AE33FQ36582523-EF312E60-1E49-4431-9B83-65D9B4C6FF3EQ36670326-1861406A-1804-435E-9D7B-8398E5A28590Q36855084-B7EE779C-C61F-46F1-BFFF-78D52EF4DF30Q37077179-0132171E-74A3-4992-AF1C-F0A78683222AQ37114336-E61B7668-696F-4B21-AC54-2576503C517BQ37286103-4C9504DC-4E10-4776-97A6-6A232E747100Q37317574-EFAE83CF-9D20-4DAF-99C5-B5C798C1B607Q37682407-4669B83D-3732-4224-9AE4-1AE3141A56A0Q38066584-7057C73B-757B-4C19-BC11-94EB35ED6E91Q38408393-2750B8CC-2F89-4104-92ED-A3259ABBF9F4Q39408346-48368478-B2F0-40F9-9E90-C50C3A0A97D5Q40825452-204AFE53-0E84-4AAA-BA5D-B5A375BAC451Q41893057-5C335844-9D2B-4595-ADA0-AF60F0A29743Q42413636-11033993-6CF6-4B6D-802E-3684049B769CQ44423986-F3A73ACC-AB3E-4BFD-8E8A-577E9CB7243FQ44510097-D13A4746-5F87-41E4-AD2F-96877B545342Q45814783-901C692B-C228-4ECD-81A3-10ED47B23329Q47151013-7DBE58A4-845D-4847-8730-6D07A38848E6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tuberous sclerosis complex: tumors and tumorigenesis.
@en
Tuberous sclerosis complex: tumors and tumorigenesis.
@nl
type
label
Tuberous sclerosis complex: tumors and tumorigenesis.
@en
Tuberous sclerosis complex: tumors and tumorigenesis.
@nl
prefLabel
Tuberous sclerosis complex: tumors and tumorigenesis.
@en
Tuberous sclerosis complex: tumors and tumorigenesis.
@nl
P2860
P50
P1476
Tuberous sclerosis complex: tumors and tumorigenesis
@en
P2093
Robert A Schwartz
P2860
P356
10.1111/J.1365-4632.2010.04727.X
P577
2011-01-01T00:00:00Z